Latest Announcements

Investor Announcement

Prana AGM Investor Conference Call

Prana invites investors unable to attend the Company’s Annual General Meeting to participate via teleconference.


Investor Announcement,

Pre-clinical evidence demonstrates PBT434 as a potential treatment for MSA

PBT434 prevents alpha-synuclein aggregation, preserves neurons, reduces glial cell inclusions and slows motor dysfunction in an animal model of Multiple System Atrophy

Email Newsletter

Receive news from Prana Biotechnology by entering your details below and clicking "Subscribe"